U.S. flag

An official website of the United States government

NM_144773.4(PROKR2):c.533G>C (p.Trp178Ser) AND Hypogonadotropic hypogonadism 3 with or without anosmia

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Mar 18, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000144714.5

Allele description [Variation Report for NM_144773.4(PROKR2):c.533G>C (p.Trp178Ser)]

NM_144773.4(PROKR2):c.533G>C (p.Trp178Ser)

Gene:
PROKR2:prokineticin receptor 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
20p12.3
Genomic location:
Preferred name:
NM_144773.4(PROKR2):c.533G>C (p.Trp178Ser)
HGVS:
  • NC_000020.11:g.5302662C>G
  • NG_008132.2:g.16708G>C
  • NM_144773.4:c.533G>CMANE SELECT
  • NP_658986.1:p.Trp178Ser
  • NC_000020.10:g.5283308C>G
  • NM_144773.2:c.533G>C
  • Q8NFJ6:p.Trp178Ser
Protein change:
W178S; TRP178SER
Links:
UniProtKB: Q8NFJ6#VAR_030961; OMIM: 607123.0008; dbSNP: rs201835496
NCBI 1000 Genomes Browser:
rs201835496
Molecular consequence:
  • NM_144773.4:c.533G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hypogonadotropic hypogonadism 3 with or without anosmia (HH3)
Synonyms:
Kallmann syndrome 3; HYPOGONADOTROPIC HYPOGONADISM 3 WITH ANOSMIA
Identifiers:
MONDO: MONDO:0009482; MedGen: C3550478; Orphanet: 478; OMIM: 244200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000190708OMIM
no assertion criteria provided
Pathogenic
(Jan 1, 2009)
germlineliterature only

PubMed (3)
[See all records that cite these PMIDs]

SCV000267467Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Mar 18, 2016)
germlinereference population

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
East Asiangermlineunknown1not providednot providednot providednot providedreference population

Citations

PubMed

Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.

Cole LW, Sidis Y, Zhang C, Quinton R, Plummer L, Pignatelli D, Hughes VA, Dwyer AA, Raivio T, Hayes FJ, Seminara SB, Huot C, Alos N, Speiser P, Takeshita A, Van Vliet G, Pearce S, Crowley WF Jr, Zhou QY, Pitteloud N.

J Clin Endocrinol Metab. 2008 Sep;93(9):3551-9. doi: 10.1210/jc.2007-2654. Epub 2008 Jun 17.

PubMed [citation]
PMID:
18559922
PMCID:
PMC2567850

Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.

Dodé C, Teixeira L, Levilliers J, Fouveaut C, Bouchard P, Kottler ML, Lespinasse J, Lienhardt-Roussie A, Mathieu M, Moerman A, Morgan G, Murat A, Toublanc JE, Wolczynski S, Delpech M, Petit C, Young J, Hardelin JP.

PLoS Genet. 2006 Oct 20;2(10):e175. Epub 2006 Sep 1.

PubMed [citation]
PMID:
17054399
PMCID:
PMC1617130
See all PubMed Citations (4)

Details of each submission

From OMIM, SCV000190708.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)

Description

In a patient with sporadic Kallmann syndrome (HH3; 244200), Dode et al. (2006) identified heterozygosity for a c.533G-C transversion in exon 2 of the PROKR2 gene, resulting in a trp178-to-ser (W178S) substitution in the T4 domain. The mutation was not found in 500 ethnically matched (Caucasian) alleles.

In a male patient with normosmic hypogonadotropic hypogonadism, Cole et al. (2008) identified heterozygosity for the W178S mutation in the PROKR2 gene. The mutation was not found in 346 control alleles. Functional analysis involving gene transcription and calcium flux assays demonstrated severely compromised activity with the W178S mutant compared to wildtype in both assays. The patient did not undergo puberty and had a normal sense of smell on olfactory testing. He exhibited a pulsatile pattern of luteinizing hormone (LH; see 152780) and had elevated LH and follicle-stimulating hormone (FSH; see 136435) levels in the setting of hypogonadal testosterone levels. Cole et al. (2008) noted that the LH secretion pattern was hypergonadotropic, although not in the range of males with primary gonadal failure, suggesting a dual hypothalamic and gonadal defect that involved insufficient GNRH (152760) secretion as well as primary gonadal resistance.

Monnier et al. (2009) performed functional analysis of the W178S mutation in HEK293 cells and observed impaired cell-surface targeting of the receptor with the W178S mutant compared to wildtype.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center, SCV000267467.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1East Asian1not providednot providedreference population PubMed (3)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

Last Updated: Sep 29, 2024